HomeCompareALTPF vs JNJ

ALTPF vs JNJ: Dividend Comparison 2026

ALTPF yields 6896.55% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALTPF wins by $1432605808592863.25M in total portfolio value
10 years
ALTPF
ALTPF
● Live price
6896.55%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1432605808592863.25M
Annual income
$1,392,875,843,310,163,600,000.00
Full ALTPF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ALTPF vs JNJ

📍 ALTPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALTPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALTPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALTPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALTPF
Annual income on $10K today (after 15% tax)
$586,206.90/yr
After 10yr DRIP, annual income (after tax)
$1,183,944,466,813,639,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ALTPF beats the other by $1,183,944,466,813,639,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALTPF + JNJ for your $10,000?

ALTPF: 50%JNJ: 50%
100% JNJ50/50100% ALTPF
Portfolio after 10yr
$716302904296431.63M
Annual income
$696,437,921,655,081,800,000.00/yr
Blended yield
97.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ALTPF
No analyst data
Altman Z
-6.9
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALTPF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALTPFJNJ
Forward yield6896.55%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1432605808592863.25M$30.3K
Annual income after 10y$1,392,875,843,310,163,600,000.00$4,689.40
Total dividends collected$1429942114786334.00M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ALTPF vs JNJ ($10,000, DRIP)

YearALTPF PortfolioALTPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$700,355$689,655.17$10,592$272.30+$689.8KALTPF
2$45,889,900$45,140,520.30$11,289$357.73+$45.88MALTPF
3$2,813,379,172$2,764,276,978.38$12,123$472.89+$2813.37MALTPF
4$161,393,449,836$158,383,134,122.24$13,141$629.86+$161393.44MALTPF
5$8,664,159,276,546$8,491,468,285,221.65$14,408$846.81+$8664159.26MALTPF
6$435,300,017,392,982$426,029,366,967,078.00$16,021$1,151.60+$435300017.38MALTPF
7$20,469,824,923,231,620$20,004,053,904,621,130.00$18,122$1,588.22+$20469824923.21MALTPF
8$901,046,035,934,427,400$879,143,323,266,569,700.00$20,930$2,228.20+$901046035934.41MALTPF
9$37,130,808,675,420,410,000$36,166,689,416,970,576,000.00$24,792$3,191.91+$37130808675420.39MALTPF
10$1,432,605,808,592,863,400,000$1,392,875,843,310,163,600,000.00$30,274$4,689.40+$1432605808592863.25MALTPF

ALTPF vs JNJ: Complete Analysis 2026

ALTPFStock

Altiplano Metals Inc., a junior resource company, focuses on evaluating and acquiring exploration projects in Chile. It explores for copper, silver, iron, and gold deposits. The company owns a 100% interest in the Farellon project and Maria Luisa project located near the town of La Serena, Republic of Chile. It also has an option to acquire a 100% undivided interest in the Pastillas gold exploration project located within the prolific Maricunga belt, the Atacama region of Chile, as well as holds interest in the San Pedro Gold project located in central Nicaragua. The company was formerly known as Altiplano Minerals Ltd. Altiplano Metals Inc. was incorporated in 2010 and is headquartered in Edmonton, Canada.

Full ALTPF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ALTPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALTPF vs SCHDALTPF vs JEPIALTPF vs OALTPF vs KOALTPF vs MAINALTPF vs ABBVALTPF vs MRKALTPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.